Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2020	Mar. 31, 2020
ASSETS
Cash and cash equivalents	$ 12,595	$ 6,790
Restricted cash and cash equivalents	1,443	1,739
Investments in marketable securities	4,314	3,820
Finance receivables, net of allowance for credit losses of $1,137 and $727	74,270	73,996
Investments in operating leases, net	35,840	36,387
Other assets	2,605	2,823
Total assets	131,067	125,555
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	105,902	97,740
Deferred income taxes	4,652	5,458
Other liabilities	5,188	7,854
Total liabilities	115,742	111,052
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2020 and March 31, 2020	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive income	26	15
Retained earnings	14,382	13,571
Total shareholder's equity	15,325	14,503
Total liabilities and shareholder's equity	$ 131,067	$ 125,555